• Publications
  • Influence
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.
This paper is the second in a series of three publications relating to the European evidence-based consensus on the diagnosis and management of Crohn's disease and concerns the management of activeExpand
  • 1,419
  • 66
  • PDF
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.
Crohn's disease is a lifelong disease arising from an interaction between genetic and environmental factors, but observed predominantly in developed countries of the world. The precise aetiology isExpand
  • 1,317
  • 53
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
Principal changes with respect to the 2004 ECCO guidelines Ileocolonoscopy is recommended within the first year after surgery where treatment decisions may be affected (Statement 8C). ThiopurinesExpand
  • 806
  • 40
  • PDF
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
J.F. Rahier ⁎, S. Ben-Horin, Y. Chowers, C. Conlon, P. De Munter, G. D'Haens, E. Domènech, R. Eliakim, A. Eser, J. Frater, M. Gassull, M. Giladi, A. Kaser, M. Lémann, T. Moreels, A. Moschen, R.Expand
  • 334
  • 31
  • PDF
Reduced Paneth cell alpha-defensins in ileal Crohn's disease.
The pathogenesis of Crohn's disease (CD), an idiopathic inflammatory bowel disease, is attributed, in part, to intestinal bacteria that may initiate and perpetuate mucosal inflammation in geneticallyExpand
  • 519
  • 26
European evidence-based Consensus on the management of ulcerative colitis: Current management.
### 5.1 General The general principles for treating active ulcerative colitis are to consider the activity, distribution (proctitis, left-sided, extensive,1 and pattern of disease (relapseExpand
  • 539
  • 22
  • PDF
Probiotic lactobacilli and VSL#3 induce enterocyte β‐defensin 2
Recent evidence suggests that probiotic bacteria may stabilize gut barrier function via induction of anti‐microbial peptides such as defensins. This study aimed to elucidate the induction mechanismExpand
  • 295
  • 21
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
This second section of the European Crohn’s and Colitis Organisation (ECCO) Consensus on the management of Crohn’s disease concerns treatment of active disease, maintenance of medically inducedExpand
  • 620
  • 19
  • PDF
European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis
Crohn’s disease (CD( is a lifelong disease arising from an interaction between genetic and environmental factors, but seen predominantly in the developed countries of the world. The precise aetiologyExpand
  • 394
  • 19
  • PDF
NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by Escherichia coli Nissle 1917: a Novel Effect of a Probiotic Bacterium
ABSTRACT Little is known about the defensive mechanisms induced in epithelial cells by pathogenic versus probiotic bacteria. The aim of our study was to compare probiotic bacterial strains such asExpand
  • 451
  • 18
  • PDF